?Np73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia (2026)
Attributed to:
Epigenomic Mechanisms of Action of Novel Mutant Isocitrate Dehydrogenase Inhibitors in Acute Myeloid Leukaemia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.xcrm.2025.102540
Publication URI: http://dx.doi.org/10.1016/j.xcrm.2025.102540
Type: Journal Article/Review
Parent Publication: Cell Reports Medicine
Issue: 1